AOD-9604 5mg – 3ml Vial

Product Overview

AOD-9604 is a modified C-terminal fragment of human growth hormone (hGH 176–191) developed for targeted research into lipolytic signalling and adipose tissue metabolism independent of full-length GH receptor activation.

In vitro and pre-clinical laboratory models utilise AOD-9604 to investigate:

• Adipocyte signalling pathways

• AMPK pathway modulation

• Lipid oxidation mechanisms

• Receptor-specific metabolic pathway activity

Unlike full-length hGH, AOD-9604 does not activate broad GH receptor cascades, making it a useful research tool in controlled metabolic pathway studies.

This compound is supplied as a lyophilised research-grade peptide to ensure stability and integrity during storage.

Key Features

• Synthetic hGH fragment (residues 176–191)

• Studied in lipid metabolism research models

• Investigated in adipocyte signalling pathways

• Does not replicate full-length GH receptor activity

• ≥99% purity (HPLC verified)

• Lyophilised solid for enhanced stability

• 5mg per sterile 3ml glass vial

Product Specifications

• Product Name: AOD-9604

• Synonyms: hGH Fragment 176–191; Anti-Obesity Drug Fragment 9604

• Molecular Class: Synthetic peptide fragment

• Amino Acid Sequence (3-Letter Code):
  Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe

• Molecular Formula: C78H123N23O23S2

• Molecular Weight: 1815.1 g/mol

• CAS Number: 221231-10-3

• Purity: ≥99% (HPLC)

• Appearance: White to off-white lyophilised powder

• Net Content: 5mg

• Vial Size: 3ml sterile glass vial

• Storage Form: Lyophilised solid

• Intended Use: Laboratory research only

Handling & Storage Guidelines

Unreconstituted (Lyophilised) Storage:
Store at −20°C for long-term preservation. Short-term storage at 2–8°C is acceptable if intended for use within 1–3 months.

Reconstituted Storage:
After reconstitution, store at 2–8°C and use within 3–6 weeks. Stability may vary depending on solvent and handling conditions.

Avoid repeated freeze–thaw cycles. Protect from excessive agitation, heat, and direct light exposure.

Manufacturing & Quality

AOD-9604 is manufactured using precision solid-phase peptide synthesis (SPPS) under GMP-aligned laboratory conditions.

Each batch undergoes:

• High Performance Liquid Chromatography (HPLC) purity verification

• Mass spectrometry identity confirmation

• Analytical quality control prior to release

• Batch traceability and documentation procedures

Products are released only after meeting strict internal quality standards.

Legal & Safety Notice

This product is supplied strictly for laboratory research purposes only.

Not for human consumption.
Not for therapeutic, diagnostic, or veterinary use.
Not a licensed medicinal product in the United Kingdom.